Research Article

Prediction of Rhizoma Drynariae Targets in the Treatment of Osteoarthritis Based on Network Pharmacology and Experimental Verification

Table 2

Chemical identification of Drynariae Rhizoma active compounds predicted by TCMSP.

NoRT (min)Mol. IDNameFormulaOB (%)DLIonCal. (m/z)Mea. (m/z)Error (ppm)MS/MS

13.82MOL005190EriodictyolC15H12O671.790.24M + H289.0706289.07111.506289.0711, 185.0035
25.39MOL009078Davallioside A_qtC19H19NO762.650.51M-H372.1088372.10903.283372.1088, 164.0430,120.0548
35.57MOL004328NaringeninC15H12O559.290.21M-H271.0611271.06092.95271.0609,185.0033
45.59MOL000569DigallateC14H10O961.850.26M + H323.0397323.0386-3.586323.0386
56.60MOL001978AureusidinC15H10O653.420.24M-H285.0404285.042.23285.04,224.9613,
67.21MOL002914Eriodictyol (flavanone)C15H12O241.350.24M-H223.0764223.0762.886223.076, 109.0276, 57.0392
77.91MOL000492CatechinC15H14O654.830.24M + H291.0863291.0861-0.737291.0861, 109.0012
88.66MOL000422KaempferolC15H10O641.880.24M-H285.0404285.04033.282228.9613,185.0038
99.23MOL001040(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-oneC15H12O542.360.21M-H271.0611271.0613.32271.061,185.0026
1010.26MOL000006LuteolinC15H10O636.160.25M-H285.0404285.04012.58285.0401,185.0138
1115.87MOL009075CycloartenoneC30H48O40.570.79M + H425.3778425.37810.722425.3781
1220.37MOL009087Marioside_qtC16H24O570.790.19M-H295.1551295.1553.387295.155,164.0452
1323.99MOL009076CyclolaudenolC31H52O39.050.79M + H441.409441.4088−2.131441.4088
1425.34MOL009091XanthogalenolC21H22O541.080.32M-H353.1394353.1391.840353.1394,191.0571
1528.62MOL000358Beta-sitosterolC29H50O36.910.75M-H413.3789413.37820.985413.3782
1628.62MOL000449StigmasterolC29H48O43.830.76M-H411.3632411.36291.841411.3629
1729.26MOL00906122-Stigmasten-3-oneC29H48O39.250.76M-H411.3632411.3632.084411.363
1829.46MOL009063Cyclolaudenol acetateC33H54O241.660.79M + H483.4197483.4196−1.221483.4196